Cerity Partners
IRWD icon

Cerity Partners’s Ironwood Pharmaceuticals IRWD Stock Holding History

Cerity Partners’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$876K Sell
208,019
-160,351
-44% -$618K ﹤0.01% 2077
2026
Q1 		$1.29M Buy
368,370
+29,858
+9% +$122K ﹤0.01% 1718
2025
Q4 		$1.14M Sell
338,512
-536
-0.2% -$1.39K ﹤0.01% 1651
2025
Q3 		$444K Sell
339,048
-641
-0.2% -$663 ﹤0.01% 2051
2025
Q2 		$244K Buy
339,689
+243,211
+252% +$191K ﹤0.01% 2256
2025
Q1 		$142K Buy
+96,478
New +$230K ﹤0.01% 2273
2024
Q2 		– Sell
-10,485
Closed -$91.3K – 2308
2024
Q1 		$91.3K Buy
+10,485
New +$127K ﹤0.01% 2210

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Cerity Partners's IRWD Position: Q2 2026 in Review

Cerity Partners reduced its Ironwood Pharmaceuticals (IRWD) stake by 44% in Q2 2026, selling an estimated $618K and leaving 208,019 shares worth $876K. The position accounts for ﹤0.01% of the portfolio, ranked #2077.

Cerity Partners first reported a position in IRWD in Q1 2024 and has held it in 7 quarters since. The position peaked at $1.29M in Q1 2026. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Cerity Partners held 208,019 shares of Ironwood Pharmaceuticals worth $876K as of Q2 2026.
  • Cerity Partners sold 160,351 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $618K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2077 holding.
  • Cerity Partners first reported a position in Ironwood Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
  • Cerity Partners's Ironwood Pharmaceuticals position peaked at $1.29M in Q1 2026.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.